134 related articles for article (PubMed ID: 9593123)
1. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.
Blázquez J; Negri MC; Morosini MI; Gómez-Gómez JM; Baquero F
Antimicrob Agents Chemother; 1998 May; 42(5):1042-4. PubMed ID: 9593123
[TBL] [Abstract][Full Text] [Related]
2. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
[TBL] [Abstract][Full Text] [Related]
3. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
[TBL] [Abstract][Full Text] [Related]
4. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
[TBL] [Abstract][Full Text] [Related]
5. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.
Sirot D; Recule C; Chaibi EB; Bret L; Croize J; Chanal-Claris C; Labia R; Sirot J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1322-5. PubMed ID: 9174192
[TBL] [Abstract][Full Text] [Related]
6. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
Moland ES; Sanders CC; Thomson KS
J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
[TBL] [Abstract][Full Text] [Related]
7. Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
Giakkoupi P; Miriagou V; Gazouli M; Tzelepi E; Legakis NJ; Tzouvelekis LS
Antimicrob Agents Chemother; 1998 May; 42(5):1281-3. PubMed ID: 9593168
[TBL] [Abstract][Full Text] [Related]
8. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam.
Sowek JA; Singer SB; Ohringer S; Malley MF; Dougherty TJ; Gougoutas JZ; Bush K
Biochemistry; 1991 Apr; 30(13):3179-88. PubMed ID: 1901218
[TBL] [Abstract][Full Text] [Related]
9. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.
Briñas L; Moreno MA; Teshager T; Zarazaga M; Sáenz Y; Porrero C; Dominguez L; Torres C
Microb Drug Resist; 2003; 9(2):201-9. PubMed ID: 12820806
[TBL] [Abstract][Full Text] [Related]
10. Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure.
Blazquez J; Morosini MI; Negri MC; Baquero F
Antimicrob Agents Chemother; 2000 Aug; 44(8):2182-4. PubMed ID: 10898697
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.
Bou G; Martínez-Beltrán J; Cerveró G; Pérez-Díaz JC
FEMS Microbiol Lett; 1999 May; 174(1):185-90. PubMed ID: 10234838
[TBL] [Abstract][Full Text] [Related]
12. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
[TBL] [Abstract][Full Text] [Related]
13. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.
Cantu C; Huang W; Palzkill T
J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421
[TBL] [Abstract][Full Text] [Related]
14. Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases.
Blazquez J; Morosini MI; Negri MC; Gonzalez-Leiza M; Baquero F
Antimicrob Agents Chemother; 1995 Jan; 39(1):145-9. PubMed ID: 7695296
[TBL] [Abstract][Full Text] [Related]
15. New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases.
Nüesch-Inderbinen MT; Hächler H; Kayser FH
Antimicrob Agents Chemother; 1995 Aug; 39(8):1726-30. PubMed ID: 7486909
[TBL] [Abstract][Full Text] [Related]
16. Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams.
Vakulenko SB; Tóth M; Taibi P; Mobashery S; Lerner SA
Antimicrob Agents Chemother; 1995 Aug; 39(8):1878-80. PubMed ID: 7486939
[TBL] [Abstract][Full Text] [Related]
17. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
[TBL] [Abstract][Full Text] [Related]
18. Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli.
Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
Clin Microbiol Infect; 2006 Aug; 12(8):800-3. PubMed ID: 16842578
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
[TBL] [Abstract][Full Text] [Related]
20. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
